Category: Pharmaceutical

Flu Laninamivir Market Size and Forecast Laninamivir, a long-acting neuraminidase inhibitor, holds a significant position in the influenza treatment market, particularly in the Asia-Pacific region. As part of the broader Neuraminidase Inhibitors…

AAT Belzutifan-like Market Size and Forecast The market for Belzutifan-like therapies, focusing on Hypoxia-Inducible Factor 2-alpha (HIF-2α) inhibitors, is rapidly emerging as a niche but high-value segment within oncology. Belzutifan itself, approved…

T1D Teplizumab Market Size and Forecast Teplizumab (Tzield) represents a novel segment within the broader Type 1 Diabetes (T1D) market, as the first FDA-approved disease-modifying therapy capable of delaying the onset of…

RSV Monoclonal Antibody Market Size and Forecast The market for Respiratory Syncytial Virus (RSV) monoclonal antibodies (mAbs) is experiencing significant expansion, driven by the shift towards long-acting prophylactic treatments for vulnerable populations….

PCD Hypertonic Saline Market Size and Forecast The market for Hypertonic Saline therapies specific to Primary Ciliary Dyskinesia (PCD) is an emerging segment within the broader respiratory and rare disease markets. While…

NAFLD Aldafermin Market Size and Forecast Aldafermin, a fibroblast growth factor 19 (FGF19) analog developed by NGM Biopharmaceuticals, targets Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). While specific market size…

COVID Peginterferon Market Size and Forecast The COVID Peginterferon market, while specialized, gained prominence due to the need for effective antiviral and immunomodulatory treatments during the pandemic. The market size is primarily…

PAH Ambrisentan Generics Market Size and Forecast The Pulmonary Arterial Hypertension (PAH) Ambrisentan generics market has emerged significantly following the patent expiration of the branded drug, Letairis. Generic availability, which began around…

Muvalaplin Market Size and Forecast Muvalaplin represents a novel therapeutic class targeting elevated lipoprotein(a) or Lp(a), a significant, independent risk factor for cardiovascular disease. As Muvalaplin is an investigational drug, the market…

MPox Brincidofovir Market Size and Forecast The market for MPox treatments, including Brincidofovir (Tembexa), is highly specialized and driven by pandemic preparedness and sporadic outbreaks. While Brincidofovir is FDA-approved for smallpox, its…